voretigene neparvovec
SpainDrugs containing this active substance
-
It is used to treat adults and children who have lost vision due to a hereditary retinal dystrophy caused by mutations in the RPE65 gene.
Form: solution for injection, concentrate and solvent
Active substance Dosage voretigene neparvovec 5 x 10¹² vg/ml Manufacturer: Novartis Europharm Limited